Notice of Funding Opportunity for Phase I Clinical Trials for HLBS Disorders
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant opportunity funds Phase I clinical trials for diagnosing and treating heart, lung, blood, and sleep (HLBS) disorders. It covers the beginning stages, implementation, and late preclinical activities of these trials, which can take place at one or multiple sites. The funding will be awarded in two phases, based on reaching specific milestones.
This NOFO supports Phase I clinical trials for diagnostic and therapeutic interventions for HLBS disorders. It includes support for clinical trial start-up, implementation, and final stage preclinical activities. The trials can be single or multi-site and will use a bi-phasic, milestone-driven m…
Source
Grant ID
PAR-25-026
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Key Dates
Opportunity Released
December 5, 2024
Eligibility
The following categories of applicants are invited to apply:
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
- Non-domestic (non-U.S.) components of U.S. Organizations
- County Governments
- City or Township Governments
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- Local Governments (General)
- State Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
Similar opportunities
- Notice of Funding Opportunity (NOFO) for Phase 1 Clinical Trials for HLBS Disorders
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
- Leveraging NICHD Clinical Research Network Infrastructure for Innovative Clinical Trials and Observational Studies
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
- Clinical Coordinating Center (CCC) for Investigator-Initiated Multi-Site Clinical Trials